| Hepatocellular carcinoma: epidemiology and molecular carcinogenesis HB El–Serag, KL Rudolph Gastroenterology 132 (7), 2557-2576, 2007 | 6678 | 2007 |
| Epidemiology of viral hepatitis and hepatocellular carcinoma HB El-Serag Gastroenterology 142 (6), 1264-1273. e1, 2012 | 4451* | 2012 |
| Rising incidence of hepatocellular carcinoma in the United States HB El-Serag, AC Mason New England Journal of Medicine 340 (10), 745-750, 1999 | 3510 | 1999 |
| Epidemiology of gastro-oesophageal reflux disease: a systematic review J Dent, HB El-Serag, MA Wallander, S Johansson Gut 54 (5), 710-717, 2005 | 2684 | 2005 |
| Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review HB El-Serag, S Sweet, CC Winchester, J Dent Gut 63 (6), 871-880, 2014 | 2226 | 2014 |
| Comprehensive and integrative genomic characterization of hepatocellular carcinoma A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ... Cell 169 (7), 1327-1341. e23, 2017 | 1914 | 2017 |
| Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications H Hampel, NS Abraham, HB El-Serag Annals of internal medicine 143 (3), 199-211, 2005 | 1725 | 2005 |
| Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma HB El-Serag, T Tran, JE Everhart Gastroenterology 126 (2), 460-468, 2004 | 1562 | 2004 |
| Epidemiology and management of hepatocellular carcinoma L Kulik, HB El-Serag Gastroenterology 156 (2), 477-491. e1, 2019 | 1457 | 2019 |
| Epidemiology of hepatocellular carcinoma KA McGlynn, JL Petrick, HB ElSerag Hepatology 73, 4-13, 2021 | 1436 | 2021 |
| The epidemiology of cholangiocarcinoma Y Shaib, HB El-Serag Seminars in liver disease 24 (02), 115-125, 2004 | 1424 | 2004 |
| Epidemiology of hepatocellular carcinoma: consider the population S Mittal, HB El-Serag Journal of clinical gastroenterology 47, S2-S6, 2013 | 1394 | 2013 |
| Diagnosis and treatment of hepatocellular carcinoma HB El-Serag, JA Marrero, L Rudolph, KR Reddy Gastroenterology 134 (6), 1752-1763, 2008 | 1338 | 2008 |
| Esophageal carcinoma AK Rustgi, HB El-Serag New England Journal of Medicine 371 (26), 2499-2509, 2014 | 1327 | 2014 |
| Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature JK Hou, B Abraham, H El-Serag Official journal of the American College of Gastroenterology| ACG 106 (4 …, 2011 | 1251 | 2011 |
| Hepatocellular carcinoma: recent trends in the United States HB El-Serag Gastroenterology 127 (5), S27-S34, 2004 | 1212 | 2004 |
| Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention DQ Huang, HB El-Serag, R Loomba Nature reviews Gastroenterology & hepatology 18 (4), 223-238, 2021 | 1206 | 2021 |
| Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression GL Davis, MJ Alter, H El–Serag, T Poynard, LW Jennings Gastroenterology 138 (2), 513-521. e6, 2010 | 1156 | 2010 |
| The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update HB El-Serag, JA Davila, NJ Petersen, KA McGlynn Annals of internal medicine 139 (10), 817-823, 2003 | 1146 | 2003 |
| Risk factors for cholangiocarcinoma GL Tyson, HB ElSerag Hepatology 54 (1), 173-184, 2011 | 1071 | 2011 |
